Faculty researcher, Scott Langenecker PhD, is helping to investigate whether nicotine, when administered correctly, could be effective delaying or preventing memory loss in patients in the early stages of Alzheimer's.... Read MorePsychiatry
Multifaceted Explorations of the Neurobiology of Depressive Disorders (MEND2)
The MEND2 laboratory uses biopsychosocial tools, including neuroimaging, performance, self-report and other-report, and blood and saliva assays in mood disorders. We use these tools to identify biomarkers to inform precision medicine, including diagnosis, risk, prevention/treatment selection, treatment effectiveness, and course modification.
Researchers at University of Utah Health and the University of Illinois at Chicago (UIC) have identified brain circuitry differences that might be associated with suicidal behavior in individuals with mood disorders. ... Read MorePsychiatry
Faculty researchers, Amanda Bakian, PhD and Scott Langenecker PhD, are conducting an on-going study that looks into how pollutant particles in the air affects mental health in Utah. ... Read MorePsychiatry
Dr. Scott Langenecker, a clinical neuropsychologist and professor of psychiatry, discusses ways people can strengthen their resilience during a free presentation titled “Images of Resilience,” at 6:30 p.m. on Wednesday, May 22, at the Park City Library’s Community Room. The event that honors Mental Health Awareness Month is sponsored by CONNECT Summit County.... Read MorePsychiatry
What Doesn’t Kill You May Not Make You Stronger: How Childhood Adversity Affects Resilience Later in Life
Researchers at University of Utah Health wanted to know if adversity during childhood rewired the brain, increasing vulnerability to mood disorders later in life. ... Read MorePsychiatry